News

The experts weighed in on a wide variety of psychiatric issues for the December 2023 issue of Psychiatric Times.

A medical student's award-winning piece on her battles with an eating disorder.

OABD is a significant concern among older adults, characterized by unique presentations and comorbidities. Here's what you need to know.

Clinicians must feel knowledgeable and masterful in incorporating lifestyle and integrative therapies targeting nutrition, stress reduction, normalization of sleep, aerobic and mindful exercise, and meaningful activities that add joy and life to years, and not just years to life.

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

Review the uses and forms of transcranial magnetic stimulation.

Captagon tablets: how are they impacting the current state of world affairs?

Although psychiatric disorders are common among older adults, many of these individuals do not get the treatment they need. The Psychiatric Times Special Report on Geriatric Psychiatry discusses how we can improve outcomes for this patient population.

Reviewing a year of CMEs in Psychiatric Times®

On Christmas, a psychiatrist shares his emboldening reflections...

Here are some highlights from Frank A. Clark, MD’s, Poetry for Inclusion from throughout 2023, as seen in Psychiatric Times.

From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.

What is new in research on schizophrenia?

In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.

One doctor shares his story of becoming a community psychiatrist.

Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

Here's how the Jewish stereotype of the hooked nose represents a greater problem: the resurgence of anti-Semitism.

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

"As I continue my medical sojourn, I am reminded that the world of health care is as diverse as the patients it serves."

Could fish oil replace antidepressants as a first-line pill for depression?

The ATA published these principles “to ensure trustworthy development, integration, and utilization of AI in order to maximize its potential benefits as a meaningful tool for patients and providers.”

"This letter I write from the heavenly ashes wishing that ebony and ivory twirl as one into the arms of divine humanity."

A transgender psychiatrist, open about her gender transition to patients and the public, just died.

Psychiatric treatment works to a degree comparable to other branches of medicine which address complex, chronic illnesses.

"A hundred skaters in Christmas red circle the lake..."

50 years ago, we stopped referring to homosexuality as a mental illness. Where are we now?

From a new look at the famous STAR*D study to updates from the National Academy of Sciences Conference on Adult ADHD, here are highlights from the week in Psychiatric Times.

What are the cardiometabolic risks of polypharmacy with quetiapine and long-acting injectable paliperidone in patients with schizophrenia?

What is new in research on ADHD?

Updates from Day 2 at the National Academy of Sciences Conference on adult ADHD.